Long-term safety and efficacy of lamotrigine (Lamictal®) in paediatric patients with epilepsy

Seizure

Volumn 6, Issue 1, 1997, Pages 51-56

  Besag, F M C ^a   Dulac, O ^b   Alving, J ^c   Mullens, E L ^d  

^a St Piers Lingfield   (United Kingdom)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c Dianalund Epilepsy Hospital   (Denmark)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Lamotrigine; Long term therapy; Paediatric epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE;

ABDOMINAL PAIN; ADOLESCENT; AGGRESSION; ALERTNESS; ARTICLE; BEHAVIOR; CHILD; CLINICAL TRIAL; CONFUSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EAR DISEASE; EPILEPSY; FEMALE; HEADACHE; HUMAN; INFECTION; INJURY; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PARESTHESIA; PHARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; RHINITIS; SEIZURE; SIDE EFFECT; SOMNOLENCE; VOMITING;

EID: 0031051979     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(97)80053-2     Document Type: Article

References (14)

1. + channels in rat hippocampal neurones. Pflügers Archives - European Journal of Physiology 1995; 430: 437-46.
2. Matsuo, F., Bergen, M. D., Faught, E., Matsuo, F., Bergen, M.D., Faught, E., Messenheimer, J.A., Dren, A.T., Rudd, G.D. and Lineberry, C.G., Placebo-controlled study of the efficiacy and safety of lamotrigine in patients with partial seizures. Neurology 1993; 43: 2284-2291.
3. Smith, D., Baker, G., Davies, G., Dewey, M. and Chadwick, D.W. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 312-322.
4. Brodie, M. J., Richens, A. and Yuen, A.W.C. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995; 345: 476-479.
5. Steiner, T.J. Comparison of lamotrigine and phenytoin monotherapy in newly diagnosed epilepsy [abstract]. Epilepsia 1994; 35 (Suppl. 8): 31.
6. Dulac, O., Withers, R.M. and Yuen, A.W.C. Add-on lamotrigine in pediatric patients with treatment-resistant epilepsy [abstract]. Epilepsia 1991; 32 (Suppl. 3): 10.
7. Schlumberger, E., Chavez, F., Palacios, L., Rey, E., Pajot, N. and Dulac, O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994; 35: 359-367.
8. Timmings, P.L. and Richens, A. Lamotrigine as an add-on drug in the management of Lennox Gastaut syndrome. European Neurology 1992; 32: 305-307.
9. Besag, F.M.C., Wallace, S.J., Dulac, O., Alving, J., Spencer, S.C. and Hosking, G. Lamotrigine for the treatment of epilepsy in childhood. Journal of Pediatrics 1995; 127: 991-997.
10. Fitton, A. and Goa, K.L. Lamotrigine - an update of its pharmacology and therapeutic use in epilepsy. Drugs 1995; 50: 691-713.
11. Gilman, J.T. and Duchowny, M. Childhood epilepsy - current therapeutic recommendations. CNS Drugs 1994; 1: 180-192.
12. Fowler, M., Besag, F. and Pool. F. Effects of lamotrigine on behavior in children [abstract]. Epilepsia 1994; 35 (Suppl. 7): 69.
13. Wyler, A.R. Modern management of epilepsy: recommended medical and surgical options. Postgraduate Medicine 1993; 94: 97-108.
14. Pugh, C.B. and Garnett, W.R. Current issues in the treatment of epilepsy. Clinical Pharmacy 1991; 10: 335-358.